Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 62

1.

ACP Journal Club. Review: corticosteroid plus LABA inhalers, vs LABAs alone, reduce morbidity in COPD.

Aaron SD.

Ann Intern Med. 2013 Feb 19;158(4):JC9. doi: 10.7326/0003-4819-158-4-201302190-02009. No abstract available.

PMID:
23420259
2.

ACP Journal Club. Review: in asthma controlled with ICSs plus LABAs, stopping LABAs increases asthma impairment.

Singh J.

Ann Intern Med. 2012 Dec 18;157(12):JC6-4. doi: 10.7326/0003-4819-157-12-201212180-02004. No abstract available.

PMID:
23247953
3.

[Twenty-five statements on early initiation of fixed combination ICS/LABA treatment for asthma and COPD in primary and secondary care: consensus research by a modified Delphi process].

Kardos P, Bechtel B, Palovis L, Hagedorn C, Latif F.

Pneumologie. 2012 Sep;66(9):549-57. doi: 10.1055/s-0032-1310076. Epub 2012 Aug 16.

4.

Survival among COPD patients using fluticasone/salmeterol in combination versus other inhaled steroids and bronchodilators alone.

Mapel DW, Nelson LS, Lydick E, Soriano J, Yood MU, Davis KJ.

COPD. 2007 Jun;4(2):127-34.

PMID:
17530506
5.

Change in asthma and COPD prescribing by Italian general practitioners between 2006 and 2008.

Cazzola M, Segreti A, Bettoncelli G, Calzetta L, Cricelli C, Pasqua F, Rogliani P.

Prim Care Respir J. 2011 Sep;20(3):291-8. doi: 10.4104/pcrj.2011.00033.

6.

ACP Journal Club. Review: oral phosphodiesterase 4 inhibitors reduce exacerbations but increase adverse events in COPD.

Ram FS.

Ann Intern Med. 2011 Sep 20;155(6):JC3-2. doi: 10.7326/0003-4819-155-6-201109200-02002. No abstract available.

PMID:
21930839
7.

Use of controller medications in patients initiated on a long-acting beta2-adrenergic agonist before and after safety alerts.

Stockl KM, Le L, Harada AS, Zhang S.

Am J Health Syst Pharm. 2008 Aug 15;65(16):1533-8. doi: 10.2146/ajhp070685.

PMID:
18693208
8.

Systematic review and economic analysis of the comparative effectiveness of different inhaled corticosteroids and their usage with long-acting beta2 agonists for the treatment of chronic asthma in children under the age of 12 years.

Main C, Shepherd J, Anderson R, Rogers G, Thompson-Coon J, Liu Z, Hartwell D, Loveman E, Green C, Pitt M, Stein K, Harris P, Frampton GK, Smith M, Takeda A, Price A, Welch K, Somerville M.

Health Technol Assess. 2008 May;12(20):1-174, iii-iv. Review.

9.
10.

Review: corticosteroids plus LABAs reduce exacerbations and mortality more than steroids alone in COPD.

Shafazand S.

Evid Based Med. 2008 Jun;13(3):74. doi: 10.1136/ebm.13.3.74. No abstract available.

PMID:
18515621
11.

ACP Journal Club. Review: Aliskiren plus ACEIs or ARBs increases hyperkalemia more than aliskiren, ACEIs, or ARBs alone.

Moist L.

Ann Intern Med. 2012 Jun 19;156(12):JC6-9. doi: 10.7326/0003-4819-156-12-201206190-02009. No abstract available.

PMID:
22711110
12.

Systematic review and economic analysis of the comparative effectiveness of different inhaled corticosteroids and their usage with long-acting beta2 agonists for the treatment of chronic asthma in adults and children aged 12 years and over.

Shepherd J, Rogers G, Anderson R, Main C, Thompson-Coon J, Hartwell D, Liu Z, Loveman E, Green C, Pitt M, Stein K, Harris P, Frampton GK, Smith M, Takeda A, Price A, Welch K, Somerville M.

Health Technol Assess. 2008 May;12(19):iii-iv, 1-360. Review.

13.

ACP Journal Club. Amoxicillin/clavulanate vs placebo: more exacerbation cures, fewer recurrences in mild-to-moderate COPD.

Adams SG, Peters JI.

Ann Intern Med. 2013 Mar 19;158(6):JC3. doi: 10.7326/0003-4819-158-6-201303190-02003. No abstract available.

PMID:
23552686
14.

ACP Journal Club. Review: Statins reduce mortality and cardiovascular (CV) morbidity in patients with low CV risk.

Muñoz D, Granger CB.

Ann Intern Med. 2012 Apr 17;156(8):JC4-07. doi: 10.7326/0003-4819-156-8-201204170-02007. No abstract available.

PMID:
22508747
15.

ACP Journal Club. Review: first-line low-dose thiazides and ACE inhibitors reduce mortality and morbidity in adults with hypertension.

Shah NR, Ogedegbe G.

Ann Intern Med. 2010 Jan 19;152(2):JC1-4. doi: 10.7326/0003-4819-152-2-201001190-02004. No abstract available.

PMID:
20083819
16.
17.

[Corticosteroid treatment in airways narrowing].

Chazan R.

Pneumonol Alergol Pol. 2008;76(2):96-100. Review. Polish.

18.

ACP Journal Club. Review: Long-term use of inhaled corticosteroids increases fracture risk in COPD.

Seggev JS.

Ann Intern Med. 2012 Mar 20;156(6):JC3-7. doi: 10.7326/0003-4819-156-6-201203200-02007. No abstract available.

PMID:
22431693
19.

Effective management of COPD in primary care - the role of long-acting beta agonist/inhaled corticosteroid combination therapy.

van Schayck CP, Reid J.

Prim Care Respir J. 2006 Jun;15(3):143-51. Epub 2006 Apr 11. Review.

20.

Supplemental Content

Support Center